Connect With Proven Diabetes Research Leaders at ADA 2026
Diabetes trials face growing enrollment complexity, tighter eligibility criteria, and increasing demands around device adherence and data quality.
Flourish Research helps sponsors overcome these barriers with experienced investigators, dedicated diabetes infrastructure, and a nationwide site network built to support high-performing studies.
- 900+ Phase I-IV diabetes studies
- Comprehensive Phase I capabilities, including overnight facilities and PK/PD sampling
- CGM/device expertise
- Deep bench of cardiologists and endocrinologists
- In-depth experience with GLP-1 therapies
Flourish Research is a leading site network in diabetes research.
Our principal investigators and site leaders will be at ADA 2026. If you’re attending, we’d love to connect and talk about your next trial.
Talk with Our PIs at ADA 2026
Connect with our experts to explore how we can accelerate enrollment for your diabetes study.
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.